Year: 2011

MASON, OHIO, Oct. 12, 2011 – AssureRx Health, Inc., and the City of Mason, Ohio, today announced an agreement to locate its new company headquarters and dry laboratory at the…

GeneSightRx® Adoption Driving Continued Expansion CINCINNATI, Sept. 7, 2011 – AssureRx Health, Inc., today announced three additions to its senior management team. These additions coincide with increasing adoption of GeneSightRx®…

CINCINNATI, May 12, 2011 – AssureRx Health, Inc., today announced two presentations on the clinical practice of utilizing its pharmacogenetic test, GeneSightRx®, at the 164th Annual Meeting of the American…

Program is Largest Commercial Pilot of AssureRx’s GeneSightRx® Test to Help Physicians Select Appropriate Medications for Individual Patients with Neuropsychiatric Disorders FRANKLIN LAKES, NJ and CINCINNATI, May 11, 2011 –…

Personalized Medicine Company to Expand Marketing and Product Development for Neuropsychiatric Pharmacogenetics CINCINNATI, March 25, 2011 – AssureRx Health, Inc. today announced the closing of an $11 million Series B…

CINCINNATI, Feb. 1, 2011 – AssureRx Health, Inc. today announced the appointments of two senior executives in key roles to drive company growth. Donald R. Wright, Jr. has been appointed…

Additional gene provides further information on drug metabolism polymorphisms CINCINNATI, Feb. 14, 2011 – AssureRx Health, Inc. today announced that it has expanded its laboratory-developed GeneSightRx® pharmacogenetic test with a…